Perception et pratique de la vaccination HPV par les gynécologues : une étude quantitative et qualitative en Rhône-Alpes

Gynécologie Obstétrique & Fertilité - Tập 39 - Trang 687-693 - 2011
D. Lutringer-Magnin1,2, J. Kalecinski3,4, G. Barone1, H. Borne5, V. Regnier3,4, P. Vanhems2,6, F. Chauvin3,4, C. Lasset1,2
1Département de santé publique, centre Léon-Bérard, 28, rue Laënnec, 69008 Lyon, France
2CNRS, UMR 5558, université de Lyon, université Lyon 1, 69100 Villeurbanne, France
3Institut de cancérologie de la Loire, 42000 Saint-Étienne, France
4IFR 143, université de Saint-Étienne, université Jean-Monnet, 42270 Saint-Priest-en-Jarez, France
5Centre hospitalier des Quatre-Villes, 92310 Sèvres, France
6Hospices civils de Lyon, hôpital Édouard-Herriot, 69003 Lyon, France

Tài liệu tham khảo

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer 2010. Belot, 2008, Cancer incidence and mortality in France over the period 1980–2005, Rev Epidemiol Sante Publique, 56, 159, 10.1016/j.respe.2008.03.117 Hospices civils de lyon, Institut de veille sanitaire, Institut national du cancer, Francim, Institut national de la santé et de la recherche médicale. Projections de l’incidence et de la mortalité par cancer en France en 2010. Anttila, 2009, Description of the national situation of cervical cancer screening in the member states of the European Union, Eur J Cancer, 45, 2685, 10.1016/j.ejca.2009.07.017 Munoz, 2003, Epidemiologic classification of human papillomavirus types associated with cervical cancer, N Engl J Med, 348, 518, 10.1056/NEJMoa021641 Zur Hausen, 2002, Papillomaviruses and cancer: from basic studies to clinical application, Nat Rev Cancer, 2, 342, 10.1038/nrc798 Fernandez, 2010, Integrating clinical, community, and policy perspectives on human papillomavirus vaccination, Annu Rev Public Health, 31, 235, 10.1146/annurev.publhealth.012809.103609 Paavonen, 2009, Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women, Lancet, 374, 301, 10.1016/S0140-6736(09)61248-4 2007, Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions, N Engl J Med, 356, 1915, 10.1056/NEJMoa061741 Haut Conseil de la santé publique. Avis relatif à la vaccination contre les infections à papillomavirus humains des jeunes filles âgées de 14 à 23ans. 2010. http://www.fncgm.com/images/Actualites_medicales_scientifiques/vaccin_pap_hcsp_12-2010.pdf. Scarinci, 2010, Cervical cancer prevention: new tools and old barriers, Cancer, 116, 2531 Davis, 2004, Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents, J Low Genit Tract Dis, 8, 188, 10.1097/00128360-200407000-00005 Ogilvie, 2010, A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt, PLoS Med, 7, e1000270, 10.1371/journal.pmed.1000270 Conroy, 2009, Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination, J Womens Health (Larchmt), 18, 1679, 10.1089/jwh.2008.1329 Piana, 2009, Standpoint and practice concerning the human Papillomavirus vaccine among French family physicians, Med Mal Inf, 39, 789, 10.1016/j.medmal.2009.08.007 Riedesel, 2005, Attitudes about human papillomavirus vaccine among family physicians, J Pediatr Adolesc Gynecol, 18, 391, 10.1016/j.jpag.2005.09.004 Duval, 2007, Vaccination against human papillomavirus: a baseline survey of Canadian clinicians’ knowledge, attitudes and beliefs, Vaccine, 25, 7841, 10.1016/j.vaccine.2007.08.041 Sussman, 2007, HPV and cervical cancer prevention counseling with younger adolescents: implications for primary care, Ann Fam Med, 5, 298, 10.1370/afm.723 Jaspan, 2008, Acceptance of human papillomavirus vaccine by gynecologists in an urban setting, J Low Genit Tract Dis, 12, 118, 10.1097/LGT.0b013e31815d9639 Raley, 2004, Gynecologists’ attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists, Infect Dis Obstet Gynecol, 12, 127, 10.1080/10647440400020661 Kahn, 2005, Pediatricians’ intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes, J Adolesc Health, 37, 502, 10.1016/j.jadohealth.2005.07.014 Daley, 2006, A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination, Pediatrics, 118, 2280, 10.1542/peds.2006-1946 Kahn, 2007, Factors influencing pediatricians’ intention to recommend human papillomavirus vaccines, Ambul Pediatr, 7, 367, 10.1016/j.ambp.2007.05.010 Ishibashi, 2008, Paediatricians’ attitudes and practices towards HPV vaccination, Acta Paediatr, 97, 1550, 10.1111/j.1651-2227.2008.00958.x Esposito, 2007, Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention, Vaccine, 25, 6437, 10.1016/j.vaccine.2007.06.053 Tissot, 2007, Effective strategies for HPV vaccine delivery: the views of pediatricians, J Adolesc Health, 41, 119, 10.1016/j.jadohealth.2007.05.007 Hopkins, 2009, UK health professionals’ attitudes and knowledge regarding Human Papillomavirus (HPV) vaccination: a West Yorkshire Study, J Paediatr Child Health, 45, 652, 10.1111/j.1440-1754.2009.01589.x Daley, 2010, Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure, Pediatrics, 126, 425, 10.1542/peds.2009-3500 Marlow, 2009, Ethnic differences in human papillomavirus awareness and vaccine acceptability, J Epidemiol Community Health, 63, 1010, 10.1136/jech.2008.085886 Zimet, 2005, Improving adolescent health: focus on HPV vaccine acceptance, J Adolesc Health, 37, S17, 10.1016/j.jadohealth.2005.09.010 Haug, 2008, Human papillomavirus vaccination – reasons for caution, N Engl J Med, 359, 861, 10.1056/NEJMe0804638 Haute Autorité de Santé. État des lieux et recommandations pour le dépistage du cancer du col de l’utérus en France ; Synthèse et recommandations. 2010. Mortensen, 2010, Drivers and barriers to acceptance of human papillomavirus vaccination among young women: a qualitative and quantitative study, BMC Public Health, 10, 68, 10.1186/1471-2458-10-68 Levy-Bruhl, 2009, The current state of introduction of HPV vaccination into national immunisation schedules in Europe: results of the VENICE 2008 survey, Eur J Cancer, 45, 2709, 10.1016/j.ejca.2009.07.023 Pearce, 2009, Physician knowledge and opinions about sexually transmitted infections and the human papillomavirus vaccine: a community-based survey, Tenn Med, 102, 33 Peto, 2004, Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort, Br J Cancer, 91, 942, 10.1038/sj.bjc.6602049 Power, 2009, Obstetrician-gynecologists’ practices and perceived knowledge regarding immunization, Am J Prev Med, 37, 231, 10.1016/j.amepre.2009.05.019 Leddy, 2009, Changes in and current status of obstetrician-gynecologists’ knowledge, attitudes, and practice regarding immunization, Obstet Gynecol Surv, 64, 823, 10.1097/OGX.0b013e3181c4bbb7 Gonik, 2000, The obstetrician-gynecologist's role in vaccine-preventable diseases and immunization, Obstet Gynecol, 96, 81, 10.1016/S0029-7844(00)00860-7 Institut de veille sanitaire. Estimation des couvertures vaccinales en secteur libéral à travers l’échantillon généraliste des bénéficiaires en France 2004–2009. 2010. Mays, 2004, Recommending STI vaccination to parents of adolescents: the attitudes of nurse practitioners, Sex Transm Dis, 31, 428, 10.1097/01.OLQ.0000130536.71812.E5 Schuster, 1996, Communication between adolescents and physicians about sexual behavior and risk prevention, Arch Pediatr Adolesc Med, 150, 906, 10.1001/archpedi.1996.02170340020004